Jefferies Has Just Reaffirmed $110.0 Target Price Per Share on Quintiles Transnational (NYSE:Q) stock, While They’ve Also Reiterated Their Hold Rating

January 16, 2018 - By Marguerite Chambers

 Jefferies Has Just Reaffirmed $110.0 Target Price Per Share on Quintiles Transnational (NYSE:Q) stock, While They’ve Also Reiterated Their Hold Rating

Investors sentiment increased to 1.53 in Q3 2017. Its up 0.60, from 0.93 in 2017Q2. It increased, as 29 investors sold IQVIA Holdings Inc. shares while 118 reduced holdings. 97 funds opened positions while 128 raised stakes. 197.84 million shares or 1.05% less from 199.95 million shares in 2017Q2 were reported.

One Natl Association reported 13,197 shares stake. Sumitomo Mitsui Holdg holds 392,406 shares or 0.05% of its portfolio. Ameriprise Inc holds 151,489 shares. Bluemountain Mgmt Ltd Limited Liability Company stated it has 0% of its portfolio in IQVIA Holdings Inc. (NYSE:Q). Lpl Fin Ltd Limited Liability Company, a California-based fund reported 8,917 shares. Ativo Mgmt Lc accumulated 26,404 shares. National Bank Of Nova Scotia owns 0.01% invested in IQVIA Holdings Inc. (NYSE:Q) for 26,188 shares. Royal Natl Bank Of Canada invested 0% in IQVIA Holdings Inc. (NYSE:Q). Moreover, Argent Com has 0.5% invested in IQVIA Holdings Inc. (NYSE:Q) for 13,425 shares. Ahl Prtnrs Ltd Liability Partnership owns 0.1% invested in IQVIA Holdings Inc. (NYSE:Q) for 56,290 shares. Federated Investors Pa invested in 0% or 5,304 shares. Fred Alger Mngmt accumulated 53 shares. Steinberg Asset Mngmt Ltd Llc holds 107,598 shares. Nomura Holdings has invested 0% of its portfolio in IQVIA Holdings Inc. (NYSE:Q). Invesco invested 0.02% of its portfolio in IQVIA Holdings Inc. (NYSE:Q).

Quintiles Transnational (NYSE:Q) Rating Reaffirmed

The financial firm has just set a price target of $110.0 on Quintiles Transnational (NYSE:Q) shares. This is 6.30 % from the stock close price. In an analyst note released on 27 October, Jefferies reiterated their Hold rating on shares of Q.

Investors sentiment increased to 1.53 in Q3 2017. Its up 0.60, from 0.93 in 2017Q2. It increased, as 29 investors sold IQVIA Holdings Inc. shares while 118 reduced holdings. 97 funds opened positions while 128 raised stakes. 197.84 million shares or 1.05% less from 199.95 million shares in 2017Q2 were reported.

One Natl Association reported 13,197 shares stake. Sumitomo Mitsui Holdg holds 392,406 shares or 0.05% of its portfolio. Ameriprise Inc holds 151,489 shares. Bluemountain Mgmt Ltd Limited Liability Company stated it has 0% of its portfolio in IQVIA Holdings Inc. (NYSE:Q). Lpl Fin Ltd Limited Liability Company, a California-based fund reported 8,917 shares. Ativo Mgmt Lc accumulated 26,404 shares. National Bank Of Nova Scotia owns 0.01% invested in IQVIA Holdings Inc. (NYSE:Q) for 26,188 shares. Royal Natl Bank Of Canada invested 0% in IQVIA Holdings Inc. (NYSE:Q). Moreover, Argent Com has 0.5% invested in IQVIA Holdings Inc. (NYSE:Q) for 13,425 shares. Ahl Prtnrs Ltd Liability Partnership owns 0.1% invested in IQVIA Holdings Inc. (NYSE:Q) for 56,290 shares. Federated Investors Pa invested in 0% or 5,304 shares. Fred Alger Mngmt accumulated 53 shares. Steinberg Asset Mngmt Ltd Llc holds 107,598 shares. Nomura Holdings has invested 0% of its portfolio in IQVIA Holdings Inc. (NYSE:Q). Invesco invested 0.02% of its portfolio in IQVIA Holdings Inc. (NYSE:Q).

IQVIA Holdings Inc. (NYSE:Q) Ratings Coverage

Among 23 analysts covering Quintiles Transnational (NYSE:Q), 8 have Buy rating, 0 Sell and 15 Hold. Therefore 35% are positive. Quintiles Transnational has $125.0 highest and $74 lowest target. $101.26’s average target is -2.15% below currents $103.48 stock price. Quintiles Transnational had 60 analyst reports since July 22, 2015 according to SRatingsIntel. Goldman Sachs downgraded the stock to “Neutral” rating in Friday, December 16 report. The firm has “Hold” rating given on Thursday, October 26 by Piper Jaffray. The rating was downgraded by Robert W. Baird on Wednesday, February 15 to “Underperform”. The firm has “Outperform” rating given on Friday, February 17 by Wells Fargo. Jefferies maintained IQVIA Holdings Inc. (NYSE:Q) on Friday, October 27 with “Hold” rating. The rating was upgraded by Zacks on Thursday, August 27 to “Hold”. The firm earned “Buy” rating on Monday, October 16 by Credit Suisse. Raymond James downgraded IQVIA Holdings Inc. (NYSE:Q) on Thursday, December 1 to “Mkt Perform” rating. The stock of IQVIA Holdings Inc. (NYSE:Q) earned “Outperform” rating by William Blair on Friday, August 4. Piper Jaffray downgraded the stock to “Neutral” rating in Thursday, October 27 report.

It closed at $103.48 lastly. It is down 27.93% since January 16, 2017 and is uptrending. It has outperformed by 11.23% the S&P500.

Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. The company has market cap of $21.87 billion. It operates through three divisions: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. It has a 424.1 P/E ratio. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations.

More news for IQVIA Holdings Inc. (NYSE:Q) were recently published by: Nasdaq.com, which released: “IQVIA Holdings Enters Oversold Territory (IQV)” on December 22, 2017. Prnewswire.com‘s article titled: “Medical Laboratories and Research Stocks’ Research Reports Released on Agilent …” and published on January 16, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: